OCTOBER 22, 2018

Result Update CYIENT LTD

Stock Details
PRICE RS.654 TARGET RS.785 BUY
Market cap (Rs mn) : 75631
52-wk Hi/Lo (Rs) : 887 / 520 Cyient 2QFY19 revenue grew by 5.1% QoQ in USD term to USD 169mn ahead
Face Value (Rs) : 5
of our estimate of USD 166.4mn. Services grew by 2.3% QoQ and DLM
3M Avg. daily vol (Nos) : 331,620
Shares o/s (mn) : 113
revenue grew by ~27% sequentially in USD terms. EBITDA margin expanded
Source:Bloomberg 152bps QoQ to 13.7% (65bps beat) on INR depreciation and operating
efficiencies.
Financial Summary
Y/E Mar (Rs mn) FY18 FY19E FY20E Key Highlights
Revenue 39,177 47,147 52,811
 Cyient revenue grew by 5.1% sequentially in dollar terms v/s our estimate of
Growth (%) 8.8 20.3 12.0
EBITDA 5,494 6,588 7,963
3.5%. Revenue from services grew by about 2.3% in USD terms sequentially
EBITDA margin (%) 14.0 14.0 15.1 and DLM grew by ~27% QoQ. Service revenue included revenue from AnSem
PAT 4,286 4,593 5,889 acquired during the year which is expected to scale further its offerings and
EPS 38.0 40.8 52.3 client base.
EPS Growth (%) 13.0 7.2 28.2
 Margins at 13.7% were about 65bps above our estimates. Margins were 152
BV (Rs/share) 208 235 274
Dividend/share (Rs) 13.0 13.0 13.0 bps higher QoQ but down 90 bps YoY, including the NBA (New Business
RONW (%) 19.2 18.4 20.5 Accelerator) impact. Services margins expansion was a function of currency
ROCE (%) 24.4 24.0 26.0 benefits (+80bps), operating efficiency (+130bps), SGA optimization
P/E (x) 17.2 16.0 12.5 (+100bps) offsetting wage hike (-100bps). Cyient has revised its FY19 margin
EV/EBITDA (x) 11.6 8.9 7.3 guidance by 50bps if the INR stays at Rs.72/USD for the rest of the year
P/BV (x) 3.1 2.8 2.4
without any cross currency headwinds, but we build in flat margins for FY19
Source: Company, Kotak Securities - PCG
due to business investments (NBA) and seasonal weakness in 3Q.
Shareholding Pattern (%)  The total order intake during the quarter grew by ~65% YoY and stood at USD
(%) Sep-18 Jun-18 Mar-18 196mn. Service order intake was at USD 157mn up 46% YoY and that for DLM
Promoters 22.1 22.2 22.2 was at USD 39mn up 233% YoY. Healthy order wins and growth in non Top 5
FII 43.1 41.4 57.0
clients reaffirm strong growth momentum, in our view.
DII 22.9 20.3 7.3
Others 21.8 16.1 13.6
Quarterly performance table
Source: Company
1QFY19 2QFY19 QoQ (%) 2QFY18 YoY (%)
Price Performance (%) Income in USD 161 169 5 150 13
(%) 1M 3M 6M Income 10,800 11,870 10 9,654 23
Cyient Ltd (8.5) (3.7) 2.9 Expenditure 9,486 10,244 8,244
Nifty (8.6) (6.2) (0.9) EBDITA 1,315 1,626 24 1,410 15
Source: Bloomberg Depreciation 285 288 259
EBIT 1,030 1,338 30 1,151
Price chart (Rs)
Interest 82 97 57
950
Other income 170 568 406
825 PBT 1,118 1,809 62 1,500 21
700 Tax 303 539 427
PAT 814 1,270 56 1,073 18
575
Sh of profit 1 1 19
450
MI & Exp items 9 0 17
Oct-17 Feb-18 Jun-18 Oct-18
Adj PAT 824 1271 54 1109 15
Source: Bloomberg
EPS (Rs) 7 11 10
Margins (%)
EBDITA 12 14 15
EBIT 10 11 12
PAT 8 11 11

Nipun Gupta Source: Company

[email protected]
+91 22 6218 6433

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 2
OCTOBER 22, 2018

Valuation & outlook

We believe Cyient is well placed to address opportunities in ER&D over long term
and expect a CAGR of ~11% revenue growth in USD terms and ~17.5% in
earnings over FY18-20. We believe Cyient’s performance in FY19 will be better
than that of its peers, and execution of its strategy of design plus manufacturing
should be reflected in financials from FY19. We value stock at 15x FY20E earnings.
We recommend BUY with a target price of Rs.785 (Rs.810 earlier).

Revenue guidance for FY19 maintained, but margin guidance raised

Cyient guided for double digit growth in its service business and 20% growth in
DLM. Including the integration of acquired B&F, DLM business is expected to
grow by 35%. DLM margins will improve slightly but are expected to remain in
low single digit due to backlog of low margin business. Tax rate which was high
at 29.8% during the quarter due to higher other income but is expected to be in
range of 24.4-25.4 %. The higher other income during the quarter was due to
incentives received by the company which are expected to continue in the future.

Vertical wise Performance

Amongst verticals, aerospace and defense (38% of revenue) will grow in high
single digits. Demand outlook remains strong though 3Q is expected to have its
share of seasonal weakness. It will come back in 4Q. Growth in FY19 will be driven
by large clients and strong growth in new accounts. Communication (21.5% of
revenue) has huge opportunity driven by spending around fixed lines and wireless
networks. Management expects double digit growth driven by momentum across
geographies and opportunities around wireless networks. Utilities & Geospatical
(12.3% of revenue) is expected to be flat YoY in FY19 though the company has
managed to build some good offerings and propositions for the market.
Transportation (10% of revenue) is on solid trajectory with rail transportation
industry expected to witness strong growth driven by healthy momentum in
rolling stock and signaling. For FY19, management remains positive on back of
strong growth in focus segments of rolling stock and signaling and growth being
driven by key clients, leading to expectation of double digit growth. Industrial &
Energy (10% of revenue) is seeing good traction from Traditional engineering and
IOT, connected devices capabilities driving good traction. Medical (3% of
revenue) has found good offering in the market with M2M. Lastly Semi conductor
(5% of revenue) growth is driven by demand for AI, IOT, 5G,AR/VR. Cyient has
been gaining traction with new automotive clients and ramp up with existing
clients. Overall growth is expected to be in double digits in FY19.

Vertical wise Growth QoQ in % (ex- Rangson) in dollar terms

Particulars 1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 2QFY19
Aerospace 1.70 2.90 4.10 -1.80 4.70 1.10
Communication 9.90 6.50 1.60 10.80 -3.20 2.30
Utiliites -7.00 -0.50 8.80 -2.20 12.50 0.70
Transportation 11.70 11.80 8.40 8.40 4.50 -0.20
Industrial energy and natural resourcers 0.10 6.10 4.30 -0.20 -3.00 2.40
Semi conductor 11.00 10.20 -6.10 -1.60 39.10 7.90
Medical consumer electronics 6.90 13.60 -2.80 1.00 -17.00 8.00
Source: Company

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 3
OCTOBER 22, 2018

Conference Call Highlights

 Revenue performance during the quarter ended was well within the band of
3-4% as expected at the beginning of the year. Strong pipeline and order
backlog give confidence that though 3Q will be a seasonally weak, 4Q should
be quite strong.
 The JV with Bluebird Aero System, Israel won its first contract from the Indian
army to supply SpyLite mini UAV systems for high altitude aerial surveillance.
The company has identified a $190mn opportunity in this area.
 Other income was Rs.397mn higher QoQ due to benefits from incentives of
Rs.234mn on merchandise and engineering and related services in DLM. This
benefits from incentives would continue through H2 FY19 and FY20. Secondly
there was unrealized gains on forex re statement of Rs.207mn during the
quarter.
 Cyient added seven projects to the New Business Accelerator (NBA) program,
taking the total to 19, and expects accelerated EPS growth from FY21
onwards.
 Reported tax was higher at 29.8% for the quarter. The tax rate is likely to be
24.4-25.4% for FY19 and down to 22-23% for FY20.

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 4
OCTOBER 22, 2018

Financials: Consolidated
Profit and Loss Statement (Rs mn) Balancesheet (Rsmn)
(Year-end Mar) FY17 FY18 FY19E FY20E (Year-end Mar) FY17 FY18 FY19E FY20E
Net Sales 36,023 39,177 47,147 52,811 Sources of Funds
% Growth 16.4 8.8 20.3 12.0 Equity Capital 562 563 563 563
Cost of Services 31,173 33,683 40,559 44,848 Reserves and Surplus 20,637 22,877 25,962 30,341
% of Net Sales 86.5 86.0 86.0 84.9 Shareholders’ Funds 21,199 23,440 26,525 30,905
Total Loan Funds 1,572 1,907 2,057 1,807
EBITDA 4,850 5,494 6,588 7,963 Total Liabilities 22,771 25,347 28,582 32,712
EBITDA Margin (%) 13.5 14.0 14.0 15.1 Appl. Of Funds
Depreciation 953 1,051 1,143 1,161 Gross Block 11,798 13,293 14,493 15,693
Accumulated Depn. 7,301 8,352 9,495 10,656
EBIT 3,897 4,443 5,445 6,802 Net Fixed Assets 4,497 4,941 4,998 5,037
Interest Exps. 189 232 327 304 Capital WIP - - 70 70
Goodwill 3,278 3,549 3,549 3,549
EBT 3,708 4,211 5,118 6,498 Investment 1,032 298 498 698
Exceptional Items 0 0 0 0 Inventories 935 1,312 1,598 1,888
Other Income 874 1,438 1,038 1,180 Sundry Debtors 6,496 6,913 8,105 9,210
Cash and Bank Bal 8,781 9,806 14,819 15,682
PBT 4,583 5,649 6,156 7,678 Other Current Asset 6,245 7,185 6,236 8,241
Tax-Total 1,047 1,387 1,569 1,786 Total Current Assets 22,457 25,216 30,757 35,021
Current Liabilities 8,493 8,656 11,291 11,662
Profit after tax 3,701 4,286 4,593 5,889 Net Current Assets 13,964 16,560 19,467 23,359
PAT Margin (%) 10.3 10.9 9.7 11.2 Total assets 22,771 25,347 28,581 32,713
Source: Company, Kotak Securities – Private Client Research Source: Company, Kotak Securities – Private Client Research

Cash flow Statement (Rs mn) Ratio Analysis

(Year-end Mar) FY17 FY18 FY19E FY20E (Year-end Mar) FY17 FY18 FY19E FY20E
Net profit before tax 4,583 5,649 6,156 7,678 Per Share (Rs)
Depreciation 953 1,051 1,143 1,161 EPS 32.9 38.0 40.8 52.3
Interest 189 232 327 304 Cash EPS 41.4 47.4 50.9 62.6
Other Income (874) (1,438) (1,038) (1,180) Book value 188.5 208.0 235.4 274.3
Opt Profit bef WC Changes 4,850 5,494 6,588 7,963 Margin (%)
WC Changes 43 (1,295) 1,327 (2,878) EBITDA 13.5 14.0 14.0 15.1
Cash Gene from Op. 4,893 4,199 7,916 5,085 EBIT 10.8 11.3 11.5 12.9
Direct Taxes Paid (1,047) (1,387) (1,569) (1,786) PAT 10.3 10.9 9.7 11.2
Cash from Ope act 3,846 2,812 6,347 3,299 Balance sheet Ratios
Purchases of F.A /CWIP (1,366) (1,495) (1,270) (1,200) Receivable (days) 65.8 64.4 62.7 63.7
Investment (234) 734 (200) (200) Inventories (days) 9.5 12.2 12.4 13.0
Others 934 1,030 858 1,027 Payables (days) 39.7 35.5 37.0 35.6
Cash from Inv Act (667) 269 (612) (373) Debt equity ratio (x)
Proc from Issue of Eq Shares (612) (536) - - Return ratios (%)
Net loans 147 335 150 (250) RONW 18.3 19.2 18.4 20.5
Interest paid (189) (232) (327) (304) RoCE 22.0 24.4 24.0 26.0
Dividend paid & Others (695) (1,623) (545) (1,509) Valuation (x)
Cash from Fin Act (1,349) (2,056) (722) (2,063) P/E 19.9 17.2 16.0 12.5
Net Increase in Cash 1,830 1,025 5,013 863 Price/Book value 3.5 3.1 2.8 2.4
Cash at Beginning 6,951 8,781 9,806 14,819 EV/EBITDA 13.4 11.6 8.9 7.3
Cash at End 8,781 9,806 14,819 15,682 EV/Sales 1.8 1.6 1.2 1.1
Source: Company, Kotak Securities – Private Client Research Source: Company, Kotak Securities – Private Client Research

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 5
OCTOBER 22, 2018

RATING SCALE
Definitions of ratings
BUY – We expect the stock to deliver more than 12% returns over the next 12 months
ACCUMULATE – We expect the stock to deliver 5% - 12% returns over the next 12 months
REDUCE – We expect the stock to deliver 0% - 5% returns over the next 12 months
SELL – We expect the stock to deliver negative returns over the next 12 months
NR – Not Rated. Kotak Securities is not assigning any rating or price target to the stock. The
report has been prepared for information purposes only.
SUBSCRIBE - We advise investor to subscribe to the IPO.
RS – Rating Suspended. Kotak Securities has suspended the investment rating and price target
for this stock, either because there is not a Sufficient fundamental basis for determining, or
there are legal, regulatory or policy constraints around publishing, an investment rating or
target. The previous investment rating and price target, if any, are no longer in effect for this
stock and should not be relied upon.
NA – Not Available or Not Applicable. The information is not available for display or is not
applicable
NM – Not Meaningful. The information is not meaningful and is therefore excluded.
NOTE – Our target prices are with a 12-month perspective. Returns stated in the rating scale are our
internal benchmark.

FUNDAMENTAL RESEARCH TEAM

Rusmik Oza Arun Agarwal Amit Agarwal Nipun Gupta Deval Shah
Head of Research Auto & Auto Ancillary Transportation, Paints, FMCG Information Tech, Midcap Research Associate
[email protected] [email protected] [email protected] [email protected] [email protected]
+91 22 6218 6441 +91 22 6218 6443 +91 22 6218 6439 +91 22 6218 6433 +91 22 6218 6423

Sanjeev Zarbade Ruchir Khare Jatin Damania Cyndrella Carvalho Ledo Padinjarathala
Cap. Goods & Cons. Durables Cap. Goods & Cons. Durables Metals & Mining, Midcap Pharmaceuticals Research Associate
[email protected] [email protected] [email protected] [email protected] [email protected]
+91 22 6218 6424 +91 22 6218 6431 +91 22 6218 6440 +91 22 6218 6426 +91 22 6218 7021

Teena Virmani Sumit Pokharna Pankaj Kumar Jayesh Kumar Krishna Nain
Construction, Cement, Buildg Mat Oil and Gas, Information Tech Midcap Economist M&A, Corporate actions
[email protected] [email protected] [email protected] [email protected] [email protected]
+91 22 6218 6432 +91 22 6218 6438 +91 22 6218 6434 +91 22 6218 5373 +91 22 6218 7907

K. Kathirvelu
Support Executive
[email protected]
+91 22 6218 6427

TECHNICAL RESEARCH TEAM

Shrikant Chouhan Amol Athawale
[email protected] [email protected]
+91 22 6218 5408 +91 20 6620 3350

DERIVATIVES RESEARCH TEAM

Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe
[email protected] [email protected] [email protected] [email protected]
+91 79 6607 2231 +91 22 6218 6420 +91 22 6218 5497 +91 33 6625 9810

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 6
OCTOBER 22, 2018

Disclosure/Disclaimer
Kotak Securities Limited established in 1994, is a subsidiary of Kotak Mahindra Bank Limited. Kotak Securities is one of India's largest brokerage and distribution house.
Kotak Securities Limited is a corporate trading and clearing member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited (NSE), Metropolitan
Stock Exchange of India Limited (MSE). Our businesses include stock broking, services rendered in connection with distribution of primary market issues and financial
products like mutual funds and fixed deposits, depository services and Portfolio Management.
Kotak Securities Limited is also a depository participant with National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). Kotak
Securities Limited is also registered with Insurance Regulatory and Development Authority as Corporate Agent for Kotak Mahindra Old Mutual Life Insurance Limited and
is also a Mutual Fund Advisor registered with Association of Mutual Funds in India (AMFI). We are registered as a Research Analyst under SEBI (Research Analyst)
Regulations, 2014.
We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in last five years.
However SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise/warning/deficiency letters/ or
levied minor penalty on KSL for certain operational deviations. We have not been debarred from doing business by any Stock Exchange / SEBI or any other authorities;
nor has our certificate of registration been cancelled by SEBI at any point of time.
We offer our research services to clients as well as our prospects.
This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person.
Persons into whose possession this document may come are required to observe these restrictions.
This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. This report is not to be construed as an offer
to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is for the general information of clients of
Kotak Securities Ltd. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual
clients.
We have reviewed the report, and in so far as it includes current or historical information, it is believed to be reliable though its accuracy or completeness cannot be
guaranteed. Neither Kotak Securities Limited, nor any person connected with it, accepts any liability arising from the use of this document. The recipients of this material
should rely on their own investigations and take their own professional advice. Price and value of the investments referred to in this material may go up or down. Past
performance is not a guide for future performance. Certain transactions -including those involving futures, options and other derivatives as well as non-investment grade
securities - involve substantial risk and are not suitable for all investors. Reports based on technical analysis centers on studying charts of a stock's price movement and
trading volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals.
Opinions expressed are our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed
in this material, there may be regulatory, compliance or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-
looking statements are not predictions and may be subject to change without notice. Our proprietary trading and investment businesses may make investment decisions
that are inconsistent with the recommendations expressed herein.
Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client
Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional
Equities Research Group of Kotak Securities Limited.
We and our affiliates/associates, officers, directors, and employees, Research Analyst(including relatives) worldwide may: (a) from time to time, have long or short positions
in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or
other compensation or act as a market maker in the financial instruments of the subject company/company (ies) discussed herein or act as advisor or lender / borrower
to such company (ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of
publication of Research Report or at the time of public appearance. Kotak Securities Limited (KSL) may have proprietary long/short position in the above mentioned
scrip(s) and therefore may be considered as interested. The views provided herein are general in nature and does not consider risk appetite or investment objective of
particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business
with KSL. Kotak Securities Limited is also a Portfolio Manager. Portfolio Management Team (PMS) takes its investment decisions independent of the PCG research and
accordingly PMS may have positions contrary to the PCG research recommendation. Kotak Securities Limited does not provide any promise or assurance of favourable
view for a particular industry or sector or business group in any manner. The investor is requested to take into consideration all the risk factors including their financial
condition, suitability to risk return profile and take professional advice before investing.
The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and
its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
No part of this material may be duplicated in any form and/or redistributed without Kotak Securities' prior written consent.
Details of Associates are available on www.kotak.com
Research Analyst has served as an officer, director or employee of subject company(ies): No
We or our associates may have received compensation from the subject company(ies) in the past 12 months.
We or our associates have managed or co-managed public offering of securities for the subject company(ies) in the past 12 months: No
We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12
months. We or our associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services
from the subject company(ies) in the past 12 months. We or our associates may have received compensation or other benefits from the subject company(ies) or third
party in connection with the research report. Our associates may have financial interest in the subject company(ies).
Research Analyst or his/her relative's financial interest in the subject company(ies): No
Kotak Securities Limited has financial interest in the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No.
Our associates may have actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of
publication of Research Report.
Research Analyst or his/her relatives has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding
the date of publication of Research Report: No.
Kotak Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of
publication of Research Report: No
By referring to any particular sector, Kotak Securities Limited does not provide any promise or assurance of favourable view for a particular industry or sector or business
group in any manner. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and take
professional advice before investing. Such representations are not indicative of future results.
Subject company(ies) may have been client during twelve months preceding the date of distribution of the research report.
"A graph of daily closing prices of securities is available at https://www.nseindia.com/ChartApp/install/charts/mainpage.jsp and
http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon in the price
chart)."
Kotak Securities Limited. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. CIN: U99999MH1994PLC134051, Telephone No.:
+22 43360000, Fax No.: +22 67132430. Website: www.kotak.com/www.kotaksecurities.com. Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City Road, A
K Vaidya Marg, Malad (East), Mumbai 400097. Telephone No: 42856825. SEBI Registration No: INZ000200137 (Member of NSE, BSE, MSE, MCX & NCDEX), AMFI ARN
0164, PMS INP000000258 and Research Analyst INH000000586. NSDL/CDSL: IN-DP-NSDL-23-97. Our research should not be considered as an advertisement or advice,
professional or otherwise. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and
the like and take professional advice before investing. Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Derivatives are a sophisticated investment device. The investor is requested to take into consideration all the risk factors before actually trading in derivative contracts.
Compliance Officer Details: Mr. Manoj Agarwal. Call: 022 - 4285 8484, or Email: [email protected].
In case you require any clarification or have any concern, kindly write to us at below email ids:
 Level 1: For Trading related queries, contact our customer service at '[email protected]' and for demat account related queries contact us at
[email protected] or call us on: Toll free numbers 18002099191 / 1800222299, Offline Customers - 18002099292
 Level 2: If you do not receive a satisfactory response at Level 1 within 3 working days, you may write to us at [email protected] or call us on 022-42858445 and
if you feel you are still unheard, write to our customer service HOD at [email protected] or call us on 022-42858208.
 Level 3: If you still have not received a satisfactory response at Level 2 within 3 working days, you may contact our Compliance Officer (Mr. Manoj Agarwal) at
[email protected] or call on 91- (022) 4285 8484.
 Level 4: If you have not received a satisfactory response at Level 3 within 7 working days, you may also approach CEO (Mr. Kamlesh Rao) at [email protected] or call
on 91- (022) 4285 8301.

Kotak Securities – Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 7